ELVN
Price
$22.10
Change
-$0.49 (-2.17%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.31B
113 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$1.02
Change
+$0.03 (+3.03%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
56.19M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELVN vs TCRX

Header iconELVN vs TCRX Comparison
Open Charts ELVN vs TCRXBanner chart's image
Enliven Therapeutics
Price$22.10
Change-$0.49 (-2.17%)
Volume$7.68K
Capitalization1.31B
TScan Therapeutics
Price$1.02
Change+$0.03 (+3.03%)
Volume$6.7K
Capitalization56.19M
ELVN vs TCRX Comparison Chart in %
ELVN
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ELVN vs. TCRX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ELVN: $22.61 vs. TCRX: $0.99)
Brand notoriety: ELVN and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 114% vs. TCRX: 97%
Market capitalization -- ELVN: $1.31B vs. TCRX: $58.45M
ELVN [@Biotechnology] is valued at $1.31B. TCRX’s [@Biotechnology] market capitalization is $58.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ELVN is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 6 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 6 bullish, 5 bearish.
  • TCRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than TCRX.

Price Growth

ELVN (@Biotechnology) experienced а +15.12% price change this week, while TCRX (@Biotechnology) price change was -18.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ELVN is expected to report earnings on Mar 12, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.31B) has a higher market cap than TCRX($56.2M). ELVN YTD gains are higher at: 0.489 vs. TCRX (-67.431). ELVN has higher annual earnings (EBITDA): -113.93M vs. TCRX (-130.55M). ELVN has more cash in the bank: 491M vs. TCRX (218M). ELVN has less debt than TCRX: ELVN (580K) vs TCRX (96.7M). TCRX has higher revenues than ELVN: TCRX (6.96M) vs ELVN (0).
ELVNTCRXELVN / TCRX
Capitalization1.31B56.2M2,335%
EBITDA-113.93M-130.55M87%
Gain YTD0.489-67.431-1%
P/E RatioN/AN/A-
Revenue06.96M-
Total Cash491M218M225%
Total Debt580K96.7M1%
TECHNICAL ANALYSIS
Technical Analysis
ELVNTCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ELVN
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REOP53.752.75
+5.39%
Reo Plastics, Inc.
UVRBF1.05N/A
N/A
Universal Robina
CNTHN41.80N/A
N/A
Connecticut Light & Power Co. (The)
IAFNF118.49-0.09
-0.08%
IA FINL CORP INC.
NDTP1.46-0.04
-2.67%
NDT Pharmaceuticals Inc.

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+2.07%
FATE - TCRX
40%
Loosely correlated
+4.83%
MGNX - TCRX
39%
Loosely correlated
+2.32%
CGEM - TCRX
38%
Loosely correlated
-2.74%
ELVN - TCRX
37%
Loosely correlated
+3.91%
ZNTL - TCRX
37%
Loosely correlated
+3.41%
More